226 related articles for article (PubMed ID: 22718488)
1. Takayasu arteritis developing during treatment of ulcerative colitis with infliximab.
Horai Y; Satoru O; Lapalme-Remis S; Sumiyoshi R; Nakashima Y; Suzuki T; Okada A; Kawashiri SY; Ichinose K; Tamai M; Yamasaki S; Nakamura H; Takeshima F; Origuchi T; Kawakami A
Mod Rheumatol; 2013 May; 23(3):572-6. PubMed ID: 22718488
[TBL] [Abstract][Full Text] [Related]
2. Ulcerative colitis is not a rare complication of Takayasu arteritis.
Watanabe R; Ishii T; Nakamura K; Shirai T; Fujii H; Saito S; Harigae H
Mod Rheumatol; 2014 Mar; 24(2):372-3. PubMed ID: 24593217
[No Abstract] [Full Text] [Related]
3. Neuroimaging of Takayasu Arteritis in a Patient with Ulcerative Rectocolitis.
Monti L; Servillo R; Grazzini I; Khader L; Acampa M; Cerase A
J Stroke Cerebrovasc Dis; 2017 Jul; 26(7):e129-e132. PubMed ID: 28479185
[TBL] [Abstract][Full Text] [Related]
4. Takayasu arteritis and ulcerative colitis; coexistence or misdiagnosis?
Azak A; Huddam B; Koçak G; Kiliç F; Koçak E; Duranay M
Sarcoidosis Vasc Diffuse Lung Dis; 2012 Mar; 29(1):53-4. PubMed ID: 23311124
[TBL] [Abstract][Full Text] [Related]
5. Takayasu arteritis associated with ulcerative colitis and optic neuritis: first case in Korea.
Pyo JY; Park JS; Song CH; Lee SW; Park YB; Lee SK
Korean J Intern Med; 2013 Jul; 28(4):491-6. PubMed ID: 23864809
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of infliximab in treating patients with ulcerative colitis: experiences from a single medical center in southern China.
Zhou YL; Xie S; Wang P; Zhang T; Lin MY; Tan JS; Zhi FC; Jiang B; Chen Y
J Dig Dis; 2014 Sep; 15(9):483-90. PubMed ID: 24828856
[TBL] [Abstract][Full Text] [Related]
7. Impact of mucosal healing on long-term outcomes in ulcerative colitis treated with infliximab: a multicenter experience.
Laharie D; Filippi J; Roblin X; Nancey S; Chevaux JB; Hébuterne X; Flourié B; Capdepont M; Peyrin-Biroulet L
Aliment Pharmacol Ther; 2013 May; 37(10):998-1004. PubMed ID: 23521659
[TBL] [Abstract][Full Text] [Related]
8. [A case of Takayasu's arteritis with ulcerative colitis diagnosed by carotodynia and MRI findings].
Kawashima M; Koike R; Nishio J; Nanki T; Kohsaka H; Kubota T; Miyasaka N
Nihon Rinsho Meneki Gakkai Kaishi; 1999 Oct; 22(5):317-23. PubMed ID: 10616284
[TBL] [Abstract][Full Text] [Related]
9. Infliximab in ulcerative colitis: real-life analysis of factors predicting treatment discontinuation due to lack of response or colectomy: ECIA (ACAD Colitis and Infliximab Study).
Fernández-Salazar L; Muñoz F; Barrio J; Muñoz C; Pajares R; Rivero M; Prieto V; Legido J; Bouhmidi A; Herranz M; Fernández N; Sánchez-Ocaña R; Joao D; Santos F
Scand J Gastroenterol; 2016; 51(2):186-95. PubMed ID: 26200929
[TBL] [Abstract][Full Text] [Related]
10. Infliximab-responsive uveitis and vasculitis in a patient with Takayasu arteritis.
Jolly M; Curran JJ
J Clin Rheumatol; 2005 Aug; 11(4):213-5. PubMed ID: 16357759
[TBL] [Abstract][Full Text] [Related]
11. Successful infliximab treatment in a patient with Takayasu arteritis associated with ulcerative colitis or migration does not override genetics.
Gecse K; Ruzsa Z; Nagy F; Wittmann T; Molnár T
Inflamm Bowel Dis; 2011 Jul; 17(7):E69-70. PubMed ID: 21538713
[No Abstract] [Full Text] [Related]
12. Abdominal pain: diagnostic issues in patient with coexisting Takayasu's arteritis and ulcerative colitis.
Kosałka J; Wawrzycka-Adamczyk K; Włudarczyk A; Machalica B; Sydor W
Kardiol Pol; 2016; 74(5):492. PubMed ID: 27197009
[No Abstract] [Full Text] [Related]
13. Disease activity, ANCA, and IL23R genotype status determine early response to infliximab in patients with ulcerative colitis.
Jürgens M; Laubender RP; Hartl F; Weidinger M; Seiderer J; Wagner J; Wetzke M; Beigel F; Pfennig S; Stallhofer J; Schnitzler F; Tillack C; Lohse P; Göke B; Glas J; Ochsenkühn T; Brand S
Am J Gastroenterol; 2010 Aug; 105(8):1811-9. PubMed ID: 20197757
[TBL] [Abstract][Full Text] [Related]
14. Hemoptysis Originating from the Bronchial Artery in Takayasu Arteritis with Ulcerative Colitis.
Imamura R; Hayashi K; Sada KE; Yamamura Y; Yamaguchi S; Morishita M; Watanabe H; Matsumoto Y; Wada J
Intern Med; 2019 Jan; 58(2):293-295. PubMed ID: 30146600
[TBL] [Abstract][Full Text] [Related]
15. Ulcerative colitis associated with Takayasu's arteritis in a child.
Balamtekin N; Gürakan F; Ozen S; Oguz B; Talim B
Acta Paediatr; 2009 Aug; 98(8):1368-71. PubMed ID: 19432836
[TBL] [Abstract][Full Text] [Related]
16. Sacroileitis and peripheral arthropathy associated with ulcerative colitis: effect of infliximab on both articular and intestinal symptoms.
Lupascu A; Armuzzi A; De Pascalis B; Carloni E; Lauritano EC; Gasbarrini A; Pola P; Gasbarrini A
Dig Liver Dis; 2004 Jun; 36(6):423-5. PubMed ID: 15248384
[TBL] [Abstract][Full Text] [Related]
17. Takayasu's disease associated with ulcerative colitis.
Sato R; Sato Y; Ishikawa H; Oshima Y; Suzuki T; Watanabe S; Oyanagi H; Sekine K; Kondo Y; Miyata M
Intern Med; 1994 Dec; 33(12):759-63. PubMed ID: 7718956
[TBL] [Abstract][Full Text] [Related]
18. Infliximab is effective for Takayasu arteritis refractory to glucocorticoid and methotrexate.
Tanaka F; Kawakami A; Iwanaga N; Tamai M; Izumi Y; Aratake K; Arima K; Kamachi M; Nakamura H; Huang M; Ida H; Origuchi T; Eguchi K
Intern Med; 2006; 45(5):313-6. PubMed ID: 16596001
[TBL] [Abstract][Full Text] [Related]
19. Managing ambulatory ulcerative colitis patients with infliximab: a long term follow-up study in primary gastroenterology centers.
Tursi A; Elisei W; Picchio M; Penna A; Lecca PG; Forti G; Giorgetti G; Faggiani R; Zampaletta C; Pelecca G; Brandimarte G
Eur J Intern Med; 2014 Oct; 25(8):757-61. PubMed ID: 25086677
[TBL] [Abstract][Full Text] [Related]
20. C-reactive protein level at 2 weeks following initiation of infliximab induction therapy predicts outcomes in patients with ulcerative colitis: a 3 year follow-up study.
Iwasa R; Yamada A; Sono K; Furukawa R; Takeuchi K; Suzuki Y
BMC Gastroenterol; 2015 Aug; 15():103. PubMed ID: 26271624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
